A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose
Clinical trial NCT00796029 · COMPLETED
Trial details
- NCT number
- NCT00796029
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.